Living with small fiber neuropathy: insights from qualitative focus group interviews.

Small fiber neuropathy biopsychosocial model chronic pain focus group pain qualitative research

Journal

The Journal of international medical research
ISSN: 1473-2300
Titre abrégé: J Int Med Res
Pays: England
ID NLM: 0346411

Informations de publication

Date de publication:
Nov 2022
Historique:
entrez: 12 11 2022
pubmed: 13 11 2022
medline: 16 11 2022
Statut: ppublish

Résumé

Small fiber neuropathy (SFN) is characterized by chronic neuropathic pain and autonomic dysfunction. Currently, symptomatic pharmacological treatment is often insufficient and frequently causes side effects. SFN patients have a reduced quality of life. However, little is known regarding whether psycho-social variables influence the development and maintenance of SFN-related disability and complaints. Additional knowledge may have consequences for the treatment of SFN. For example, factors such as thinking, feeling, and behavior are known to play roles in other chronic pain conditions. The aim of this study was to obtain further in-depth information about the experience of living with SFN and related chronic pain. Fifteen participants with idiopathic SFN participated in a prospective, semi-structured, qualitative, focus group interview study. The focus groups were audio-recorded, transcribed, and analyzed cyclically after each interview. The following main themes were identified: "pain appraisal", "coping", "social, work, and health environment", and "change in identity". Catastrophic thoughts and negative emotions were observed. Living with SFN resulted in daily limitations and reduced quality of life. Given the results, it can be concluded that an optimal treatment should include biological, psychological, and social components.

Identifiants

pubmed: 36369665
doi: 10.1177/03000605221132463
pmc: PMC9663626
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3000605221132463

Références

Pain. 2000 Apr;85(3):317-332
pubmed: 10781906
Health Qual Life Outcomes. 2015 Oct 15;13:169
pubmed: 26467421
Pain. 2016 Oct;157(10):2318-2329
pubmed: 27429174
J Pain. 2015 Sep;16(9):807-13
pubmed: 26051220
Eur J Neurol. 2018 Feb;25(2):348-355
pubmed: 29112785
Br J Anaesth. 2008 Jul;101(1):25-31
pubmed: 18511440
Clin J Pain. 2001 Jun;17(2):165-72
pubmed: 11444718
Pain. 2003 Dec;106(3):453-460
pubmed: 14659529
Aust N Z J Public Health. 2007 Oct;31(5):433-7
pubmed: 17931290
Qual Life Res. 2009 Nov;18(9):1263-78
pubmed: 19784865
J Adv Nurs. 2005 Aug;51(4):421-8
pubmed: 16086811
Pain. 2010 Sep;150(3):573-581
pubmed: 20705215
J Peripher Nerv Syst. 2019 Mar;24(1):19-33
pubmed: 30569495
Drugs Aging. 2015 Aug;32(8):611-21
pubmed: 26239827
Muscle Nerve. 2014 Mar;49(3):329-36
pubmed: 23716362
Disabil Rehabil. 2009;31(17):1402-8
pubmed: 19479570
Brain. 2019 Dec 1;142(12):3728-3736
pubmed: 31665231
J Behav Med. 2007 Feb;30(1):77-94
pubmed: 17180640
Eur J Neurol. 2006 Nov;13(11):1153-69
pubmed: 17038030
J Clin Epidemiol. 1998 Nov;51(11):1055-68
pubmed: 9817123
Diabetes Metab Syndr Obes. 2013;6:79-92
pubmed: 23403729
Clin J Pain. 2001 Mar;17(1):52-64
pubmed: 11289089
Pain. 2005 Feb;113(3):310-315
pubmed: 15661438
J Peripher Nerv Syst. 2015 Sep;20(3):333-40
pubmed: 26114213
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
AIDS Care. 2011 Aug;23(8):921-8
pubmed: 21500021
Psychol Health. 2019 Jan;34(1):84-105
pubmed: 30320508
Expert Rev Neurother. 2020 Sep;20(9):967-980
pubmed: 32654574
Int J Qual Stud Health Well-being. 2014 Oct 16;9:26152
pubmed: 25326092
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Neurology. 2013 Oct 8;81(15):1356-60
pubmed: 23997150
Curr Pain Headache Rep. 2010 Oct;14(5):331-8
pubmed: 20680705
Pain Pract. 2017 Mar;17(3):320-328
pubmed: 27006136
Lancet Neurol. 2015 Feb;14(2):162-73
pubmed: 25575710
Pain Pract. 2017 Sep;17(7):866-878
pubmed: 27782366

Auteurs

Aysun Damci (A)

MHeNS, School for Mental Health and Neuroscience, 6200 MD Maastricht, The Netherlands.
Department of Neurology, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.

Janneke G J Hoeijmakers (JGJ)

MHeNS, School for Mental Health and Neuroscience, 6200 MD Maastricht, The Netherlands.
Department of Neurology, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.

Jeroen de Jong (J)

Care and Public Health Research Institute, Maastricht University, 6200 MD Maastricht, The Netherlands.
Department of Rehabilitation Medicine, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.
Intergrin, 6167 AC Geleen, The Netherlands.

Catharina G Faber (CG)

MHeNS, School for Mental Health and Neuroscience, 6200 MD Maastricht, The Netherlands.
Department of Neurology, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.

Maria A C de Mooij (MAC)

Care and Public Health Research Institute, Maastricht University, 6200 MD Maastricht, The Netherlands.
Department of Rehabilitation Medicine, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.

Jeanine A M C F Verbunt (JAMCF)

Care and Public Health Research Institute, Maastricht University, 6200 MD Maastricht, The Netherlands.
Department of Rehabilitation Medicine, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.
Adelante Zorggroep, Center of Rehabilitation Medicine, 6432 CC Hoensbroek, The Netherlands.

Mariëlle E J B Goossens (MEJB)

Care and Public Health Research Institute, Maastricht University, 6200 MD Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH